Australia TGA Medical Device Registration – Overview
Medical Device Registration Australia: Medical devices in Australia are regulated by the Therapeutic Goods Administration (TGA). For a product to be legally supplied in Australia, it must be included in the Australian Register of Therapeutic Goods (ARTG). All foreign manufacturers must appoint an Australian TGA Sponsor a locally established entity responsible for submitting applications, managing ongoing compliance, and acting as the liaison with TGA.
Masuu Global Solutions supports manufacturers across the full TGA regulatory process, helping companies achieve efficient, compliant, and timely ARTG inclusion.
Australia Medical Device Regulatory Framework
Regulatory Authority:
Therapeutic Goods Administration (TGA)Primary Regulation:
Australian Therapeutic Goods (Medical Devices) Regulations 2002Regulatory Pathway:
ARTG Inclusion (TGA conformity assessment + sponsor submission)Authorized Representative Requirement:
Australian Sponsor (mandatory for non‑Australian manufacturers)QMS Requirement:
ISO 13485:2016 or MDSAP certificationTechnical Review:
TGA assessment of evidence, testing, and conformity documentationLicense Validity:
Registration remains valid indefinitely, provided annual ARTG fees are paidLabeling Requirements:
Compliance with Essential Principle 13, Schedule 1 of the RegulationsSubmission Format:
Electronic submission through TGA Business Services (TBS)Submission Language:
EnglishTGA Medical Device Classification
Australia’s medical device classification framework is closely aligned with the EU system, categorizing devices by risk level.Non‑IVD Medical Device Classes
| Class | Risk Level |
| Class I | Low Risk |
| Class IIa | Low–Moderate Risk |
| Class IIb | Moderate–High Risk |
| Class III | High Risk |
| AIMD | High Risk (Active Implantable Devices) |
IVD Device Classes
| Class | Risk Level |
| Class 1 | No public health risk / Low personal risk |
| Class 2 | Low public health risk / Moderate personal risk |
| Class 3 | Moderate public health risk / High personal risk |
| Class 4 | High public health risk |
Medical Device Sponsor Requirements
In Australia, the manufacturer must partner with a TGA‑recognized Sponsor who:- Acts as the regulatory representative
- Submits ARTG inclusion applications
- Maintains all documentation for inspections
- Communicates with the TGA on behalf of the manufacturer
- Ensures post‑market compliance
Australia Medical Device Registration Process
-
Class I Devices
For Class I non‑sterile, non‑measuring devices:
- The manufacturer submits a Declaration of Conformity
- The Sponsor files for ARTG listing via TBS
- ARTG inclusion is typically immediate
-
Higher‑Risk Devices (Class IIa, IIb, III, AIMD, IVDs)
The Sponsor must provide:
- Australian Declaration of Conformity
- QMS certification (ISO 13485:2016 or MDSAP)
- Evidence of conformity (e.g., CE certificate, GHTF/MDSAP audit reports)
- Class III & AIMD
- Specified Class IIb devices
- Class 4 IVDs
- Selected Class 3 IVD categories
Post‑Approval Lifecycle Management (Australia)
Masuu supports full lifecycle compliance, including:- Change management for device variations, accessories, and new indications
- Annual ARTG fee management
- License renewals and amendments
- Ongoing communication with TGA
- Compliance monitoring and regulatory intelligence
- Maintaining product safety and performance documentation
TGA Registration Summary
| Risk Level | Device Class | QMS Audit Requirement | Regulatory Pathway | TGA Timelines |
| Low | Class I | Not Applicable | ARTG Listing | Immediate |
| Low–Moderate | Class IIa | ISO 13485 / MDSAP | ARTG Listing | 230–250 TGA working days |
| Moderate–High | Class IIb | ISO 13485 / MDSAP | ARTG Listing | 230–250 TGA working days |
| High | Class III | ISO 13485 / MDSAP | ARTG Listing | 230–250 TGA working days |
Masuu’s Medical Device Registration Services for Australia
Regulatory Support
- TGA Pre‑Submission Meetings
- TGA device classification & grouping
- Conformity assessment guidance
- MDSAP implementation support
- ARTG inclusion support
Documentation & Compliance
- Labeling compliance review
- Technical documentation support
- Internal audits, mock audits & QMS readiness checks
Representation & Operations
- Australian Sponsor support
- E‑Business System (TBS) account setup & management
- Distributor identification & qualification
- Post‑market surveillance & reporting
- License renewal & transfer
- End‑to‑end submission & TGA communication
Frequently Asked Questions
Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG) before they can be legally supplied in Australia. The process involves determining the device classification, meeting applicable conformity assessment requirements, preparing supporting documentation, appointing an Australian Sponsor when required, and submitting the ARTG application electronically through TGA Business Services.
Yes. Non-Australian medical device manufacturers must appoint an Australian Sponsor that is locally established. The Sponsor submits ARTG inclusion applications, communicates with the Therapeutic Goods Administration (TGA), maintains required documentation, and supports ongoing regulatory and post-market compliance activities on behalf of the manufacturer.
The Australian Register of Therapeutic Goods (ARTG) is the register of therapeutic goods that can be legally supplied in Australia. Medical device manufacturers generally need to obtain ARTG inclusion before supplying their devices. The inclusion process requires the manufacturer and Sponsor to meet applicable TGA regulatory and conformity assessment requirements.
Australia classifies non-IVD medical devices according to risk as Class I, Class IIa, Class IIb, Class III, and Active Implantable Medical Devices (AIMD). IVDs use a separate Class 1 through Class 4 system. The classification determines the applicable conformity assessment pathway, evidence requirements, QMS expectations, and level of TGA oversight.
For eligible Class I medical devices, the manufacturer prepares a Declaration of Conformity and the Australian Sponsor submits the ARTG inclusion application through TGA Business Services. For Class I non-sterile, non-measuring devices, the page indicates that ARTG inclusion is typically immediate, subject to meeting the applicable requirements.
Higher-risk devices such as Class IIa, IIb, III, AIMD, and applicable IVDs require supporting conformity documentation. Depending on the device, this can include an Australian Declaration of Conformity, ISO 13485:2016 or MDSAP certification, and evidence of conformity such as relevant certificates, audit reports, testing, and technical documentation.
Mandatory TGA audits can apply to certain higher-risk devices. The page identifies Class III and AIMD devices, specified Class IIb devices, Class 4 IVDs, and selected Class 3 IVD categories as examples. The applicable audit requirements depend on the device classification and regulatory pathway.
The registration timeline depends on the device classification and applicable regulatory pathway. The page identifies immediate ARTG listing for eligible Class I non-sterile, non-measuring devices, while Class IIa, IIb, and III devices are listed with indicative TGA timelines of approximately 230–250 working days. Actual timelines can depend on review and submission requirements.
ISO 13485:2016 or MDSAP certification is identified as a QMS requirement for applicable higher-risk medical devices in the Australian registration process. The required conformity assessment evidence depends on the device classification and pathway. Manufacturers should determine the applicable QMS and conformity requirements before preparing an ARTG submission.
ARTG inclusion does not end the manufacturer’s regulatory responsibilities. Ongoing compliance can involve annual ARTG fee management, changes to devices and indications, license amendments or transfers, post-market surveillance, safety and performance documentation, regulatory communication, and continued compliance with TGA requirements throughout the device lifecycle.
